[Pharmacological considerations on cetiedil, a drug with prevalent hemodynamic activity].
D000818:Animals; D001001:Anura; D001381:Azepines / Q000494:pharmacology*; D001786:Blood Glucose / Q000096:biosynthesis; D001794:Blood Pressure / Q000187:drug effects; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects*; D007422:Intestines / Q000187:drug effects; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D013876:Thiophenes / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects*; D014661:Vasoconstriction / Q000187:drug effects
D001381:Azepines; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D011941:Receptors, Adrenergic; D013876:Thiophenes; C006955:cetiedil
Considerazioni farmacologiche sul cetiedile, farmaco a prevalente attivitdà emodinamica.